Cargando…
SAT-638 An Academic Center Experience with the Eversense Continuous Glucose Monitoring System and Assessment of Intrapatient Variability with Repeated Same-Pocket Insertion
BACKGROUND: The Eversense continuous glucose monitoring (ECGM) system is a 90-day implantable device approved for patients with diabetes. The manufacturer recommends alternating arms each subsequent insertion to ensure adequate healing. To date, the intra-patient sensor variability using the same su...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209292/ http://dx.doi.org/10.1210/jendso/bvaa046.468 |